Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01147029 | GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy | terminated | Phase 1 | 35 | Cancer Research UKOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT00442741 | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) | withdrawn | Phase 1 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 25, 2012 | clinicaltrials |
| NCT00573690 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 31 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00741234 | A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine | completed | Phase 1 | 85 | S*BIOINDUSTRY | 2 | Apr 23, 2012 | clinicaltrials |
| NCT00389922 | Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | University of California, DavisOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01106248 | QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | Eisai LimitedINDUSTRY | 1 | Apr 13, 2012 | clinicaltrials |
| NCT00969410 | A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases | completed | Phase 1 | 19 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 12, 2012 | clinicaltrials |
| NCT00636545 | Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors | completed | Phase 1 | 25 | Genta IncorporatedINDUSTRY | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00307255 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors | completed | Phase 1 | 18 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00949559 | Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors | completed | Phase 1 | 38 | Esperance Pharmaceuticals IncINDUSTRY | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00253474 | PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma | completed | Phase 1 | 36 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00703378 | Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle | completed | Phase 1 / Phase 2 | 33 | National University Hospital, SingaporeOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00804310 | Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors(UCDCC#207) | terminated | Phase 1 | 5 | University of California, DavisOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01072890 | Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors | completed | Phase 1 | 8 | University of California, DavisOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01469052 | First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors | completed | Phase 1 | 36 | PfizerINDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01381341 | To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. | completed | Phase 1 | 13 | AbbottINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00030108 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00095914 | Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00356980 | TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00387608 | ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | 23 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT01337310 | Study of Tesetaxel in Japanese Patients With Solid Tumors | unknown | Phase 1 | 12 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00908908 | A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 6 | Eisai Inc.INDUSTRY | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00062049 | Interleukin-7 in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00589381 | Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 47 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Mar 6, 2012 | clinicaltrials |
| NCT00606814 | Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 6, 2012 | clinicaltrials |
| NCT00469937 | Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases | terminated | Phase 1 | 9 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00737555 | A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours | completed | Phase 1 | 23 | Chroma TherapeuticsINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00661414 | Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors(ASONEP) | completed | Phase 1 | 37 | Lpath, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00949624 | CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors | completed | Phase 1 | 50 | Arog Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 19, 2012 | clinicaltrials |
| NCT00296062 | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | terminated | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT01509300 | HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors | unknown | Phase 1 / Phase 2 | 10 | Asan Medical CenterOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 30 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Dec 22, 2011 | clinicaltrials |
| NCT00069264 | Study of E7389 in Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | Eisai Inc.INDUSTRY | 1 | Dec 20, 2011 | clinicaltrials |
| NCT01491204 | Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer | completed | Phase 1 | 25 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 0 | Dec 13, 2011 | clinicaltrials |
| NCT00935844 | Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 20 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00831896 | Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies | completed | Phase 1 | 27 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 2, 2011 | clinicaltrials |
| NCT00697879 | Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours | completed | Phase 1 | 40 | Chroma TherapeuticsINDUSTRY | 2 | Nov 28, 2011 | clinicaltrials |
| NCT01401933 | Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 14 | AbbottINDUSTRY | 1 | Nov 2, 2011 | clinicaltrials |
| NCT00977210 | Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | Mateon TherapeuticsINDUSTRY | 1 | Oct 31, 2011 | clinicaltrials |
| NCT00524524 | An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors | completed | Phase 1 | 9 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Oct 19, 2011 | clinicaltrials |
Data updated 23 days agoSource updated May 1, 2012source: clinicaltrials